4//SEC Filing
DENNER ALEXANDER J 4
Accession 0000899140-23-000758
CIK 0001080014other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 9:00 PM ET
Size
8.0 KB
Accession
0000899140-23-000758
Insider Transaction Report
Form 4
Innoviva, Inc.INVA
Denner Alexander J
10% Owner
Transactions
- Purchase
Common Stock, par value $0.01 per share
2023-06-15$13.13/sh+62,000$814,196→ 7,277,000 total(indirect: See footnotes)
Sarissa Capital Management LP
10% Owner
Transactions
- Purchase
Common Stock, par value $0.01 per share
2023-06-15$13.13/sh+62,000$814,196→ 7,277,000 total(indirect: See footnotes)
Footnotes (3)
- [F1]On June 15, 2023, the Reporting Persons acquired 62,000 shares of Common Stock at a weighted average price of $13.1322 per share. The shares were purchased in multiple open market transactions at prices ranging from $13.075 to $13.18 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Sarissa Capital Management LP ("Sarissa Capital") is the investment advisor to Sarissa Capital Offshore Master Fund LP, Sarissa Capital Catapult Fund LLC, Sarissa Capital Hawkeye Fund LP and Sarissa Capital Master Fund II LP (collectively, the "Sarissa Funds") and may be deemed to beneficially own the shares of Common Stock directly beneficially owned by the Sarissa Funds by virtue of the authority granted to it to vote and to dispose of the securities held by them, including the shares of Common Stock. Alexander J. Denner, Ph.D., a citizen of the United States of America ("Dr. Denner"), is the Chief Investment Officer and ultimate general partner of Sarissa Capital and is the ultimate general partner, or controls the managing member, of each of the Sarissa Funds; accordingly, Dr. Denner may be deemed to beneficially own the shares of Common Stock directly held by the Sarissa Funds by virtue of such positions.
- [F3]Each of Dr. Denner, Sarissa Capital and each of the Sarissa Funds disclaims beneficial ownership of the shares of Common Stock reported herein except, in each case, to the extent of their pecuniary interest therein.
Documents
Issuer
Innoviva, Inc.
CIK 0001080014
Entity typeother
Related Parties
1- filerCIK 0001361754
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 9:00 PM ET
- Size
- 8.0 KB